A synthetic anti-inflammatory sterol improves insulin sensitivity in insulin-resistant obese impaired glucose tolerance subjects.
Saved in:
| Title: | A synthetic anti-inflammatory sterol improves insulin sensitivity in insulin-resistant obese impaired glucose tolerance subjects. |
|---|---|
| Authors: | Reading CL; Harbor Therapeutics, Inc., San Diego, California, USA., Stickney DR, Flores-Riveros J, Destiche DA, Ahlem CN, Cefalu WT, Frincke JM |
| Source: | Obesity (Silver Spring, Md.) [Obesity (Silver Spring)] 2013 Sep; Vol. 21 (9), pp. E343-9. Date of Electronic Publication: 2013 May 13. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101264860 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1930-739X (Electronic) Linking ISSN: 19307381 NLM ISO Abbreviation: Obesity (Silver Spring) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
